Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rani Therapeutics Holdings

1.64
+1.17248.27%
Post-market: 1.830.2000+12.27%19:59 EDT
Volume:492.84M
Turnover:802.14M
Market Cap:117.86M
PE:-1.82
High:2.39
Open:1.37
Low:1.13
Close:0.4709
52wk High:2.78
52wk Low:0.3870
Shares:71.87M
Float Shares:33.62M
Volume Ratio:1,115.49
T/O Rate:1466.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9027
EPS(LYR):-1.0541
ROE:-1187.52%
ROA:-93.94%
PB:-21.14
PE(LYR):-1.56

Loading ...

BUZZ-U.S. STOCKS ON THE MOVE- SLB NV, Bank OZK, Gilead Sciences

Reuters
·
Yesterday

US Stocks Movements | Rani Therapeutics (RANI.US) Soars Over 265% After $1.085 Billion Partnership Agreement with Chugai Pharmaceutical

Stock News
·
Oct 17

Rani Therapeutics Secures New Loan Agreement

TIPRANKS
·
Oct 17

Rani Therapeutics Holdings Shares Nearly Triple After up to $1.09 Billion Licensing Deal With Japan's Chugai Pharma

THOMSON REUTERS
·
Oct 17

Rani Therapeutics Shares More Than Double Premarket After up to $1.09 Billion Licensing Deal With Japan's Chugai Pharma

THOMSON REUTERS
·
Oct 17

Rani Therapeutics Shares Double After Deal With Chugai Pharma

Dow Jones
·
Oct 17

Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma

Reuters
·
Oct 17

Rani Therapeutics prices 42.6M shares at 48c in private placement

TIPRANKS
·
Oct 17

Rani Therapeutics Amends Loan Agreement With Avenue, Converts $6 Million Debt Into Equity and Warrants

Reuters
·
Oct 17

Rani Therapeutics announces $1.085B collaboration with Chugai Pharmaceutical

TIPRANKS
·
Oct 17

BRIEF-Rani Therapeutics Announces Up To $1.085 Billion Collaboration With Chugai Pharmaceutical Co. For Multiple High-Value Therapeutics Including Rare Disease And Immunology Programs And Announces Concurrent Oversubscribed $60.3 Million Financing

Reuters
·
Oct 17

Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Oct 17

Press Release: Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Dow Jones
·
Oct 17

Rani Therapeutics Holdings : Chugai Has Option to Extend Rights to Partner With Co on up to 5 Additional Drug Targets

THOMSON REUTERS
·
Oct 17

Rani Therapeutics Holdings Inc - Announces $60.3 Mln Private Placement Financing

THOMSON REUTERS
·
Oct 17

Rani Therapeutics Announces up to $1.085 Billion Collaboration With Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing

THOMSON REUTERS
·
Oct 17

BRIEF-Rani Therapeutics Holdings Files For Mixed Shelf Offering Of Up To $200 Million - SEC Filing

Reuters
·
Aug 09

Rani Therapeutics Files $200 Million Mixed Shelf

MT Newswires Live
·
Aug 09

Rani Therapeutics Holdings Inc Files for Mixed Shelf Offering of up to $200 Mln - SEC Filing

THOMSON REUTERS
·
Aug 09

Rani Therapeutics to Initiate Phase 1 Trial for Oral Obesity Therapy, RT-114, in Second Half of 2025

Reuters
·
Aug 08